Log in
Enquire now
PEP-Therapy

PEP-Therapy

Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Board of Directors
‌
Antoine Prestat
0
CEO
‌
Antoine Prestat
0
Competitors
Eternygen GmbH
Eternygen GmbH
0
Country
France
France
Crunchbase URL
crunchbase.com/organiz...-therapy
Email Address
0
Founded Date
2014
0
Founder
‌
Antoine Prestat
0
Full Address
Pépinière Paris Santé Cochin 29 rue du Faubourg Saint Jacques 75014 Paris – France
0
Pépinière Genopole Entreprises 4 rue Pierre Fontaine 91058 Evry Cedex – France
0
Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Healthcare
Healthcare
Biology
Biology
Technology
Technology
Drug delivery
Drug delivery
0
Drug discovery
Drug discovery
0
Biotechnology
Biotechnology
0
Therapeutics
Therapeutics
Investors
‌
Magna Capital Partners
0
Doorway Capital
Doorway Capital
0
Seventure Partners
Seventure Partners
Latest Funding Round Date
July 20, 2021
Latest Funding Round Amount (USD)
3,100,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/pep-therapy
Location
Paris
Paris
0
France
France
0
Number of Employees
12
0
Number of Employees (Ranges)
11 – 50
Phone Number
0
Pitchbook URL
pitchbook.com/profiles...112264-03
Public/Private
Private
0
Total Funding Amount (USD)
3,100,000

Find more companies like PEP-Therapy

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.